Structures by: Salas J. M.
Total: 213
C5H16CoN11S
C5H16CoN11S
Journal of Coordination Chemistry (2003) 56, 1581-1586
a=12.1950(6)Å b=9.0317(5)Å c=12.6017(7)Å
α=90.00° β=113.4190(10)° γ=90.00°
Bis(2,2'-biimidazole)copper(II) perchlorate bis(4,7-dihydro-1,2,4-triazolo[1,5-a]pyrimidine-7-one
C22H20Cl2CuN16O10
Journal of Chemical Crystallography (2004) 34, 8 549-552
a=19.666(2)Å b=11.7586(8)Å c=13.4808(9)Å
α=90.00° β=103.690(8)° γ=90.00°
Tetrakis(4,5-dihydro-1,2,4-triazolo[1,5-a]pyrimidinate-5-one-mu-N3,N4) dipalladium(II) tetrahydrate
C20H20N16O8Pd2
Polyhedron (2004) 23, 2373-2379
a=12.864(2)Å b=14.634(2)Å c=30.703(3)Å
α=90.00° β=90.00° γ=90.00°
Bis(4,5-dihydro-1,2,4-triazolo[1,5-a]pyrimidinate-5-one-mu-N3,N4) bis(trans-diaminociclohexane) dipalladium(II) nitrate tetrahydrate
C22H40N14O11Pd2
Polyhedron (2004) 23, 2373-2379
a=10.2842(15)Å b=18.920(3)Å c=18.450(3)Å
α=90.00° β=104.117(10)° γ=90.00°
ClCoCr2H20N6O8
ClCoCr2H20N6O8
Journal of Coordination Chemistry (2005) 58, 217-223
a=10.0218(9)Å b=9.3216(8)Å c=16.2203(13)Å
α=90.00° β=112.962(6)° γ=90.00°
(Cu3Cl2(OH)3(2-pymo)(4,4'-bpy)1.5)n(NO3)n.6.25nH2O
C34H41.5Cl2Cu3N9O12.25
Dalton transactions (Cambridge, England : 2003) (2005) 9 1743-1746
a=17.076(3)Å b=19.341(3)Å c=13.481(2)Å
α=90.00° β=90.00° γ=90.00°
C10H12CuN10O10
C10H12CuN10O10
Acta Crystallographica Section E (2003) 59, m903-m905
a=14.4717(5)Å b=6.4247(2)Å c=18.4846(6)Å
α=90.00° β=90.00° γ=90.00°
Trans-Dichloro bis(3-amino-1,2,4-triazolium-N^1^) copper(II) tetrachlorocuprate(II) dihydrate.
C4H10Cl2CuN82,Cl4Cu2,2(H2O)
Acta Crystallographica Section E (2004) 60, m370-m372
a=6.1505(6)Å b=7.6367(8)Å c=9.7197(10)Å
α=95.0132(15)° β=99.9045(15)° γ=110.2812(14)°
C5H4CdN10
C5H4CdN10
CrystEngComm (2010) 12, 3038-3045
a=3.6149(2)Å b=11.4499(7)Å c=12.1649(8)Å
α=70.789(1)° β=82.385(1)° γ=86.674(1)°
C12H8CdN10S2
C12H8CdN10S2
CrystEngComm (2010) 12, 3038-3045
a=8.3799(19)Å b=19.526(4)Å c=10.357(2)Å
α=90.00° β=90.00° γ=90.00°
C24H20Co2N20O2S4
C24H20Co2N20O2S4
CrystEngComm (2010) 12, 3038-3045
a=12.510(3)Å b=12.902(3)Å c=12.175(3)Å
α=90.00° β=116.431(3)° γ=90.00°
C12H8N10O2Zn
C12H8N10O2Zn
CrystEngComm (2010) 12, 3038-3045
a=11.918(5)Å b=11.340(5)Å c=12.434(5)Å
α=90.000(5)° β=115.472(5)° γ=90.000(5)°
C12H12MnN10O2S2
C12H12MnN10O2S2
CrystEngComm (2010) 12, 3038-3045
a=8.6882(7)Å b=12.6477(10)Å c=9.0639(7)Å
α=90.00° β=111.7360(10)° γ=90.00°
C24H20N20Ni2O2S4
C24H20N20Ni2O2S4
CrystEngComm (2010) 12, 3038-3045
a=12.3178(8)Å b=12.8907(8)Å c=12.1015(8)Å
α=90.00° β=115.818(1)° γ=90.00°
C12H8N10S2Zn
C12H8N10S2Zn
CrystEngComm (2010) 12, 3038-3045
a=8.3561(8)Å b=9.8609(9)Å c=11.2066(10)Å
α=86.6056(14)° β=71.8330(13)° γ=71.3906(13)°
Catena-bis(5-fluoro-pyrimidin-2-olate)-pd(ii) bisaquo
C8H8F2N4O4Pd1
Journal of Materials Chemistry (2007) 17, 19 1939
a=16.31134(85)Å b=16.31134(85)Å c=16.31134(85)Å
α=90° β=90° γ=90°
Catena-bis(5-fluoro-pyrimidin-2-olate)-pd(ii)
C8H4F2N4O2Pd1
Journal of Materials Chemistry (2007) 17, 19 1939
a=16.29569(84)Å b=16.29569(84)Å c=16.29569(84)Å
α=90° β=90° γ=90°
C32H34N24O10Zn2,2(H2O)
C32H34N24O10Zn2,2(H2O)
Dalton Transactions (2009) 46 10311-10317
a=10.3170(9)Å b=10.3555(9)Å c=11.0667(9)Å
α=97.483(1)° β=100.866(1)° γ=112.462(1)°
C32H38Cd2N24O12,6(H2O)
C32H38Cd2N24O12,6(H2O)
Dalton Transactions (2009) 46 10311-10317
a=10.5968(5)Å b=10.7757(5)Å c=11.7018(6)Å
α=90.286(1)° β=105.216(1)° γ=114.417(1)°
C32H30Cu2N24O8,5(H2O)
C32H30Cu2N24O8,5(H2O)
Dalton Transactions (2009) 46 10311-10317
a=8.2470(13)Å b=10.8660(17)Å c=12.1170(19)Å
α=80.533(19)° β=80.839(19)° γ=88.072(19)°
C7H4CdN6O2
C7H4CdN6O2
CrystEngComm (2010) 12, 3038-3045
a=3.5617(4)Å b=11.4103(13)Å c=12.0524(14)Å
α=71.286(2)° β=83.404(2)° γ=87.609(2)°
C17H18CdN8O8
C17H18CdN8O8
CrystEngComm (2016) 18, 30 5647
a=10.5290(4)Å b=11.3431(4)Å c=18.5469(8)Å
α=90° β=101.742(2)° γ=90°
C30H20Cd2N16O16,2(CH4O)
C30H20Cd2N16O16,2(CH4O)
CrystEngComm (2016) 18, 30 5647
a=8.7461(7)Å b=10.5696(8)Å c=11.8018(9)Å
α=95.426(3)° β=105.576(3)° γ=95.516(3)°
C12H6FeN9O12,C5H5N,4(H2O)
C12H6FeN9O12,C5H5N,4(H2O)
Dalton transactions (Cambridge, England : 2003) (2016) 45, 41 16166-16172
a=13.4941(13)Å b=14.2216(15)Å c=14.0514(14)Å
α=90° β=111.062(5)° γ=90°
C6H15Cl2CoN4O14
C6H15Cl2CoN4O14
Dalton transactions (Cambridge, England : 2003) (2011) 40, 19 5180-5187
a=12.923(5)Å b=6.542(5)Å c=10.446(5)Å
α=90.00° β=90.00° γ=90.00°
C24H28Cl2CuN16O14
C24H28Cl2CuN16O14
Dalton transactions (Cambridge, England : 2003) (2011) 40, 19 5180-5187
a=11.752(2)Å b=11.663(2)Å c=12.921(2)Å
α=90.00° β=101.396(2)° γ=90.00°
C12H20Cl2CuN8O14
C12H20Cl2CuN8O14
Dalton transactions (Cambridge, England : 2003) (2011) 40, 19 5180-5187
a=14.166(5)Å b=13.435(5)Å c=13.405(5)Å
α=90.00° β=102.357(5)° γ=90.00°
C8H13CuN5O7
C8H13CuN5O7
Dalton transactions (Cambridge, England : 2003) (2012) 41, 6 1755-1764
a=6.927(5)Å b=7.603(5)Å c=13.009(5)Å
α=87.030(5)° β=81.785(5)° γ=71.481(5)°
C5H5N5
C5H5N5
Dalton transactions (Cambridge, England : 2003) (2012) 41, 6 1755-1764
a=3.7456(4)Å b=11.8913(12)Å c=13.0276(13)Å
α=90.00° β=97.8090(10)° γ=90.00°
C20H30Cl4Cu2N20O21
C20H30Cl4Cu2N20O21
Dalton transactions (Cambridge, England : 2003) (2012) 41, 6 1755-1764
a=18.291(3)Å b=18.838(3)Å c=12.285(2)Å
α=90.00° β=90.610(3)° γ=90.00°
C12H10CuN10O4,3(H2O)
C12H10CuN10O4,3(H2O)
Dalton transactions (Cambridge, England : 2003) (2012) 41, 6 1755-1764
a=25.0574(10)Å b=6.8244(3)Å c=24.2133(9)Å
α=90.00° β=116.800(5)° γ=90.00°
C14H18CuN10O6
C14H18CuN10O6
Dalton transactions (Cambridge, England : 2003) (2012) 41, 6 1755-1764
a=7.2299(8)Å b=11.3987(12)Å c=12.7792(12)Å
α=90.00° β=117.793(5)° γ=90.00°
(tetrakisacetonitrile-bis(mu-1,2,4-triazolo(1,5- a)pyrimidine)disilver(i)) bis(tetrafluoroborate)
C18H20Ag2N12,2(BF4)
Dalton transactions (Cambridge, England : 2003) (2011) 40, 44 11845-11855
a=6.2201(2)Å b=10.6272(2)Å c=11.5588(8)Å
α=110.016(8)° β=99.817(7)° γ=91.442(6)°
(tetrakisacetonitrile-bis(mu-1,2,4-triazolo(1,5- a)pyrimidine)disilver(i)) bis(perchlorate)
C18H20Ag2N12,2(ClO4)
Dalton transactions (Cambridge, England : 2003) (2011) 40, 44 11845-11855
a=6.32530(10)Å b=10.7545(2)Å c=11.5478(8)Å
α=110.093(8)° β=100.489(7)° γ=90.426(6)°
(bis(mu-7-amine-1,2,4-triazolo(1,5-a)pyrimidine)disilver(i)) bis(perchlorate)
C10H10Ag2N10,2(ClO4)
Dalton transactions (Cambridge, England : 2003) (2011) 40, 44 11845-11855
a=5.7889(15)Å b=8.389(2)Å c=10.138(3)Å
α=109.414(3)° β=91.774(3)° γ=102.566(3)°
(acetonitrile-bis(mu-5,7-dimethyl-1,2,4-triazolo(1,5- a)pyrimidine)disilver(i)) tetrafluoroborate perchlorate
C16H19Ag2N9,F6P,ClO4
Dalton transactions (Cambridge, England : 2003) (2011) 40, 44 11845-11855
a=11.228(5)Å b=11.471(5)Å c=12.191(5)Å
α=110.932(5)° β=112.874(5)° γ=97.284(5)°
(bis(mu-trifluoromethylsulfonate)-bis(mu-5,7-dimethyl-1,2,4- triazolo(1,5-a)pyrimidine)disilver(i))
C8H8AgF3N4O3S
Dalton transactions (Cambridge, England : 2003) (2011) 40, 44 11845-11855
a=8.3689(2)Å b=8.6550(2)Å c=9.0743(6)Å
α=93.984(7)° β=94.541(7)° γ=112.430(8)°
Catena-(bis(mu-1,2,4-triazolo(1,5-a)pyrimidine)disilver(i)) bis(hexafluorophosphate) hexahydrate
C5H4AgN4O0.12,F6P
Dalton transactions (Cambridge, England : 2003) (2011) 40, 44 11845-11855
a=26.0272(3)Å b=26.0272(3)Å c=11.0746(2)Å
α=90.00° β=90.00° γ=120.00°
C40H38Cl2N8O11S4Zn
C40H38Cl2N8O11S4Zn
CrystEngComm (2014) 16, 36 8322
a=16.529(2)Å b=16.529(2)Å c=16.604(2)Å
α=90.00° β=90.00° γ=90.00°
C42H32MnN10S6
C42H32MnN10S6
CrystEngComm (2014) 16, 36 8322
a=9.694(3)Å b=11.143(4)Å c=11.326(3)Å
α=87.71(4)° β=76.90(3)° γ=67.65(4)°
C12H8N4O2SZn
C12H8N4O2SZn
CrystEngComm (2014) 16, 36 8322
a=14.545(3)Å b=14.834(3)Å c=12.805(4)Å
α=90° β=90° γ=90°
C22H16FeN6S4,2(H2O)
C22H16FeN6S4,2(H2O)
CrystEngComm (2014) 16, 36 8322
a=17.001(6)Å b=10.288(4)Å c=16.629(6)Å
α=90° β=118.53(4)° γ=90°
C40H38Cl2N8O11S4Zn
C40H38Cl2N8O11S4Zn
CrystEngComm (2014) 16, 36 8322
a=16.529(2)Å b=16.529(2)Å c=16.604(2)Å
α=90.00° β=90.00° γ=90.00°
C42H32MnN10S6
C42H32MnN10S6
CrystEngComm (2014) 16, 36 8322
a=9.694(3)Å b=11.143(4)Å c=11.326(3)Å
α=87.71(4)° β=76.90(3)° γ=67.65(4)°
C12H8N4O2SZn
C12H8N4O2SZn
CrystEngComm (2014) 16, 36 8322
a=14.545(3)Å b=14.834(3)Å c=12.805(4)Å
α=90° β=90° γ=90°
C22H16FeN6S4,2(H2O)
C22H16FeN6S4,2(H2O)
CrystEngComm (2014) 16, 36 8322
a=17.001(6)Å b=10.288(4)Å c=16.629(6)Å
α=90° β=118.53(4)° γ=90°
C18H30N12NiO2
C18H30N12NiO2
Inorganica Chimica Acta (2011) 378, 194-201
a=8.841(5)Å b=8.667(5)Å c=16.086(5)Å
α=90.00° β=110.00(2)° γ=90.00°
C8H26CoN7O8
C8H26CoN7O8
Journal of Molecular Structure (2006) 784, 222-227
a=10.2635(18)Å b=9.0480(15)Å c=9.752(2)Å
α=90.00° β=104.493(12)° γ=90.00°
C18H29CuN13O4
C18H29CuN13O4
Polyhedron (2010) 29, 372-378
a=8.4355(6)Å b=40.985(3)Å c=7.1685(5)Å
α=90.00° β=113.298(1)° γ=90.00°
C10H18N2O4Zn2,2(C6H6N5O21)
C10H18N2O4Zn2,2(C6H6N5O21)
Polyhedron (2009) 28, 911-916
a=8.4090(9)Å b=8.9126(9)Å c=9.9452(10)Å
α=86.016(2)° β=86.980(2)° γ=66.6810(10)°
C6H9N5O3
C6H9N5O3
Journal of Molecular Structure (1995) 344, 257-264
a=10.679(2)Å b=5.814(1)Å c=13.794(3)Å
α=90.0000° β=97.31(3)° γ=90.0000°
C34H26Cl2N12O12Pd2
C34H26Cl2N12O12Pd2
J. Chem. Soc., Dalton Trans. (2002) 24 4740-4745
a=15.468(6)Å b=20.652(10)Å c=25.162(5)Å
α=90.00° β=90.00° γ=90.00°
Bis(4,5-dihydro-1,2,4-triazolo[1,5-a]pyrimidinate-5-one-mu-N3-N4) bis(phenanthroline)dipalladium(II) nitrate tetrahydrate
C34H30N14O12Pd2
Polyhedron (2004) 23, 2373-2379
a=19.688(12)Å b=14.219(12)Å c=14.448(6)Å
α=90.00° β=110.02(4)° γ=90.00°
Diaqua bis(4,7-dihydro-1,2,4-triazolo[1,5-a]pyrimidine-7-one-N3)zinc(II) tetrah
C10H18N8O8Zn
Polyhedron (2004) 23, 743-747
a=7.5430(8)Å b=13.1384(12)Å c=17.2599(10)Å
α=90.00° β=90.00° γ=90.00°
5,7-dimethyl-1,2,4-triazolo[1,5-a]pyrimidinium tetrachlorocobaltate(II) monohydrate
2C7H9N4,Cl4Co2,H2O
Acta Crystallographica, Section E (2005) 61, 9 m1721-m1723
a=7.6369(4)Å b=8.5190(4)Å c=18.2777(9)Å
α=84.9520(10)° β=84.5050(10)° γ=65.2750(10)°
C10H12CuN10O10
C10H12CuN10O10
Acta Crystallographica, Section E: Structure Reports Online (2003) 59, 10d m903-m905
a=14.4717(5)Å b=6.4247(2)Å c=18.4846(6)Å
α=90.00° β=90.00° γ=90.00°
Trans-Bis(3-amino-1,2,4-triazolium-κN^1^)dichlorocopper(II) tetrachlorocuprate(II) dihydrate
C4H10Cl2CuN82,Cl4Cu2,2H2O
Acta Crystallographica, Section E (2004) 60, 4 m370-m372
a=6.1505(6)Å b=7.6367(8)Å c=9.7197(10)Å
α=95.0132(15)° β=99.9045(15)° γ=110.2812(14)°
C14H16Cl2N8Zn1
C14H16Cl2N8Zn1
Acta Crystallographica Section C (1994) 50, 4 510-512
a=10.5210(10)Å b=18.425(3)Å c=18.449(2)Å
α=90.° β=90.° γ=90.°
C21H32Cl2CuN12O12
C21H32Cl2CuN12O12
Acta Crystallographica Section C (1993) 49, 11 1902-1905
a=11.176(2)Å b=11.879(2)Å c=14.026(2)Å
α=96.390(10)° β=92.840(10)° γ=112.800(10)°
(C5H9N4S)2[ZnBr4]
(C5H9N4S)2[ZnBr4]
Acta Crystallographica Section C (1995) 51, 12 2532-2534
a=8.790(2)Å b=8.790(2)Å c=24.831(5)Å
α=90° β=90° γ=120°
1,2,4-Triazolo[1,5-a]pyrimidin-1-ium chloride
C5H5N4,Cl
Acta Crystallographica Section E (2007) 63, 3 o1509-o1510
a=6.4813(6)Å b=9.8306(9)Å c=21.623(2)Å
α=90.00° β=90.00° γ=90.00°
4,6-Dimethyl-2H-1,2,3-triazolo[4,5-d]pyrimidine-5,7(4H,6H)-dione--4,7-phenanthroline (1/1)
C6H7N5O2,C12H8N2
Acta Crystallographica Section E (2007) 63, 5 o2727-o2727
a=7.9787(9)Å b=11.8174(13)Å c=17.7359(19)Å
α=90.00° β=102.674(2)° γ=90.00°
C15H18CoN3O12
C15H18CoN3O12
Acta Crystallographica Section C (1994) 50, 12 1875-1878
a=10.6500(10)Å b=13.8950(10)Å c=13.8920(10)Å
α=90.00000° β=99.550(10)° γ=90.00000°
C12H12N10NiO4S2
C12H12N10NiO4S2
Acta Crystallographica, Section C (2000) 56, 934-935
a=7.8040(3)Å b=7.9946(3)Å c=8.9870(3)Å
α=106.331(3)° β=108.534(3)° γ=105.041(3)°
Inosinium tetrabromo-gold(iii) dihydrate
C10H13N4O51,Au1Br41,2(H2O1)
Acta Crystallographica, Section C (1989) 45, 1874-1877
a=7.430(1)Å b=8.272(2)Å c=8.768(3)Å
α=98.96(2)° β=108.02(2)° γ=94.56(2)°
2-methylthio-8-azaxanthine
C5H5N5OS,H2O
Acta Crystallographica Section C (2006) 62, 8 o489-o491
a=17.1216(12)Å b=7.3269(5)Å c=14.3494(10)Å
α=90.00° β=113.2590(10)° γ=90.00°
4,7-Phenanthrolinium perchlorate--5-methyl-1,2,4-triazolo[1,5-<i>a</i>]pyrimidin-7(4<i>H</i>)-one-- water (1/1/2)
C12H9N2,ClO4,C6H6N4O,2(H2O)
Acta Crystallographica Section E (2010) 66, 2 o459-o460
a=8.6082(8)Å b=14.7723(14)Å c=16.8079(17)Å
α=90.00° β=104.609(2)° γ=90.00°
Bis(cyanato-κ<i>N</i>)bis(5,7-dimethyl-1,2,4-triazolo[1,5-<i>a</i>]pyrimidine- κ<i>N</i>^3^)zinc
C16H16N10O2Zn
Acta Crystallographica Section E (2011) 67, 3 m345
a=10.0023(15)Å b=10.8168(16)Å c=11.1094(16)Å
α=116.772(2)° β=107.226(2)° γ=98.557(2)°
Bis(7-amino-1,2,4-triazolo[1,5-<i>a</i>]pyrimidin-4-ium) bis(oxalato-κ^2^<i>O</i>^1^,<i>O</i>^2^)cuprate(II) dihydrate
2(C5H6N5),C4CuO82,2(H2O)
Acta Crystallographica Section E (2011) 67, 11 m1531-m1532
a=3.6599(2)Å b=24.1977(10)Å c=11.1963(5)Å
α=90.00° β=92.344(4)° γ=90.00°
C24H30ClCu3N13O14
C24H30ClCu3N13O14
Journal of the American Chemical Society (2001) 123, 383-387
a=15.7600(3)Å b=15.7600(3)Å c=15.7600(3)Å
α=90.00° β=90.00° γ=90.00°
[Cu(2-pymo)2]n.(NH4NO3.2H2O)n/3
C24H24.5Cu3N14O12.25
Journal of the American Chemical Society (2004) 126, 3014-3015
a=15.6702(5)Å b=15.6702(5)Å c=15.6702(5)Å
α=90.00° β=90.00° γ=90.00°
[(Cu(2-pymo)2)2RbNO3(H2O)]n.nMeOH
C17H20Cu2N9O10Rb
Journal of the American Chemical Society (2004) 126, 3014-3015
a=18.7829(19)Å b=11.0197(11)Å c=11.4504(11)Å
α=90.00° β=90.00° γ=90.00°
[Cu(2-pymo)2]n.[Li(H2O)4]n/3(NO3)n/3
C24H26Cu3LiN13O13
Journal of the American Chemical Society (2004) 126, 3014-3015
a=15.6475(5)Å b=15.6475(5)Å c=15.6475(5)Å
α=90.00° β=90.00° γ=90.00°
Hydrated Cu(2-pymo)2
C8H8CuN4O3
Journal of the American Chemical Society (2004) 126, 3014-3015
a=23.0400(15)Å b=23.0400(15)Å c=25.1398(18)Å
α=90° β=90° γ=120°
Tetraaquo-bis(5-nitro-pyrimidin-2-olate)-cobalt(ii)
C8H12CoN6O10
Inorganic Chemistry (2005) 44, 1472-1481
a=7.62079Å b=11.53322Å c=8.67176Å
α=90° β=101.1926° γ=90°
Catena bis(5-nitro-pyrimidin-2-olate) cobalt(ii)
C8H4CoN6O6
Inorganic Chemistry (2005) 44, 1472-1481
a=24.8865Å b=9.67178Å c=9.44625Å
α=90° β=90° γ=90°
Tetraaquo-bis(5-nitro-pyrimidin-2-olate)-nickel(ii)
C8H12N6NiO10
Inorganic Chemistry (2005) 44, 1472-1481
a=7.502977Å b=11.46582Å c=8.750554Å
α=90° β=101.7807° γ=90°
Catena bis(5-nitro-pyrimidin-2-olate) zinc(ii)
C8H4N6O6Zn
Inorganic Chemistry (2005) 44, 1472-1481
a=25.3228Å b=9.62696Å c=9.43197Å
α=90° β=90° γ=90°
Catena-tetrakis(N,N'-pyrimidin-2-olate)-biscopper(ii)-potassium nitrate- -hydrate-methanol solvate
C8.5H9CuK0.5N4.5O4.5
Inorganic Chemistry (2007) 46, 2988-2997
a=10.177(7)Å b=11.416(12)Å c=11.033(3)Å
α=90.00° β=110.72(5)° γ=90.00°
Catena-tetrakis(N,N'-pyrimidin-2-olate)-biscopper(ii)-rubidium nitrate- -hydrate-methanol solvate
C8.5H9CuN4.5O4.5Rb0.5
Inorganic Chemistry (2007) 46, 2988-2997
a=19.0696(14)Å b=11.0596(8)Å c=11.4266(9)Å
α=90.00° β=90.00° γ=90.00°
Catena-tetrakis(N,N'-pyrimidin-2-olate)-biscopper(ii)-tallium nitrate- -methanol solvate
C8.5H8CuN4.5O4Tl0.5
Inorganic Chemistry (2007) 46, 2988-2997
a=19.044(2)Å b=11.0370(10)Å c=11.451(3)Å
α=90.00° β=90.00° γ=90.00°
Zn(4-pymo)2
C8H6N4O2Zn
Inorganic Chemistry (2004) 43, 473-481
a=21.04152(35)Å b=21.04152(35)Å c=11.42935(22)Å
α=90° β=90° γ=120°
Ni(4-pymo)2
C8H6N4NiO2
Inorganic Chemistry (2004) 43, 473-481
a=6.51413(69)Å b=6.51413(69)Å c=20.9318(29)Å
α=90° β=90° γ=90°
Ni(4-pymo)2(H2O)4
C8H14N4NiO6
Inorganic Chemistry (2004) 43, 473-481
a=13.42758(42)Å b=12.90329(45)Å c=6.75501(19)Å
α=90° β=90° γ=90°
C28H36Br4Cu2N16O2
C28H36Br4Cu2N16O2
Inorganic Chemistry (1994) 33, 5477-5481
a=9.614(4)Å b=12.370(6)Å c=9.645(4)Å
α=99.01(3)° β=60.17(3)° γ=79.61(4)°
C50H62N19Ni2O81,C6H6N5O21,CH4O,2(H2O)
C50H62N19Ni2O81,C6H6N5O21,CH4O,2(H2O)
Inorganic Chemistry Communications (2010) 13, 1081-1084
a=12.1449(6)Å b=23.9300(12)Å c=22.4250(11)Å
α=90.00° β=102.462(2)° γ=90.00°
Trans-Tetra-aqua-bis(xanthosinato-N)-zinc(ii) dihydrate
C20H30N8O16Zn1,2(H2O1)
Inorganic Chemistry (1991) 30, 2916-2921
a=8.065(1)Å b=8.502(1)Å c=11.066(1)Å
α=81.52(1)° β=84.67(1)° γ=82.73(1)°
Tetrakis(mu-4,7-H-5methyl-7-oxo-s- triazolo(1,5a)pyrimidinato)diplatinum(II) bis(dimethylsulphoxide) solvate
C28H32N16O6Pt2S2
Inorganic Chemistry (1996) 35, 26 7829-7835
a=14.207(3)Å b=15.187(3)Å c=17.165(3)Å
α=90.00° β=90.00° γ=90.00°
C8H8CuN6O2S2
C8H8CuN6O2S2
Inorganic Chemistry (1997) 36, 4988-4991
a=8.408(2)Å b=10.581(3)Å c=7.927(2)Å
α=89.45(2)° β=77.44(2)° γ=69.75(2)°
C14H16Ag2N82,2(ClO4),H2O
C14H16Ag2N82,2(ClO4),H2O
Journal of inorganic biochemistry (2019) 201, 110810
a=8.9978(4)Å b=10.8619(5)Å c=12.0576(6)Å
α=100.5189(16)° β=105.2550(16)° γ=93.1937(17)°
C14H16Ag2B2F8N8,2(C21H24Ag2N122),4(BF4),2(H2O)
C14H16Ag2B2F8N8,2(C21H24Ag2N122),4(BF4),2(H2O)
Journal of inorganic biochemistry (2019) 201, 110810
a=12.0038(3)Å b=27.5554(8)Å c=12.8479(4)Å
α=90° β=100.9670(10)° γ=90°
C14H24MnN8O42,2(C7H8N4),2(ClO41),2(H2O)
C14H24MnN8O42,2(C7H8N4),2(ClO41),2(H2O)
European Journal of Medicinal Chemistry (2014) 85, 526-534
a=14.9135(8)Å b=8.5203(5)Å c=17.7690(10)Å
α=90.00° β=111.617(1)° γ=90.00°
C14H24FeN8O42,2(C7H8N4),2(ClO41),2(H2O)
C14H24FeN8O42,2(C7H8N4),2(ClO41),2(H2O)
European Journal of Medicinal Chemistry (2014) 85, 526-534
a=14.8776(11)Å b=8.5567(6)Å c=17.6690(13)Å
α=90.00° β=111.748(1)° γ=90.00°
C14H24N8NiO42,2(C7H8N4),2(ClO41),2(H2O)
C14H24N8NiO42,2(C7H8N4),2(ClO41),2(H2O)
European Journal of Medicinal Chemistry (2014) 85, 526-534
a=14.8078(8)Å b=8.6073(5)Å c=17.5587(10)Å
α=90.00° β=112.121(1)° γ=90.00°
C28H36CuN16O22,2(ClO41),2(H2O)
C28H36CuN16O22,2(ClO41),2(H2O)
European Journal of Medicinal Chemistry (2014) 85, 526-534
a=8.6399(9)Å b=11.9756(12)Å c=19.1916(18)Å
α=90.00° β=90.352(1)° γ=90.00°
C14H24N8O4Zn2,2(C7H8N4),2(ClO41),2(H2O)
C14H24N8O4Zn2,2(C7H8N4),2(ClO41),2(H2O)
European Journal of Medicinal Chemistry (2014) 85, 526-534
a=14.830(2)Å b=8.5741(12)Å c=17.618(2)Å
α=90.00° β=111.980(2)° γ=90.00°
C10H8N2,CdH12O62,2(C6H6N5O21)
C10H8N2,CdH12O62,2(C6H6N5O21)
Dalton Transactions (2012) 10390-10395
a=8.5931(4)Å b=9.0396(4)Å c=10.9308(5)Å
α=109.292(1)° β=107.638(1)° γ=101.821(1)°
C20H24CdN4O4S22,2(C6H6N5O21)
C20H24CdN4O4S22,2(C6H6N5O21)
Dalton Transactions (2012) 10390-10395
a=8.4223(6)Å b=10.1249(7)Å c=11.7854(8)Å
α=100.942(1)° β=99.816(1)° γ=94.821(1)°
C10H8N2,H12MnO62,2(C6H6N5O21)
C10H8N2,H12MnO62,2(C6H6N5O21)
Dalton Transactions (2012) 10390-10395
a=8.5570(12)Å b=9.1663(13)Å c=10.9500(15)Å
α=108.647(2)° β=108.125(2)° γ=101.431(2)°
C12H12N2,H12MnO62,2(C6H6N5O21)
C12H12N2,H12MnO62,2(C6H6N5O21)
Dalton Transactions (2012) 10390-10395
a=8.5542(6)Å b=10.5222(7)Å c=10.7110(7)Å
α=65.084(1)° β=71.622(1)° γ=67.507(1)°